Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Clinical

  • 1
    News

    Transition to high-sensitivity troponin T assay helped boost ED discharge rates

    October 26, 2018

    SAN DIEGO – The study marks the first analysis of its kind in the United States.

  • 1
    Article

    Daptomycin/fosfomycin: A new standard for MRSA bacteremia?

    October 25, 2018

    Better survival was seen for MRSA bacteremia at 7 days using the combo vs. monotherapy.

  • 1
    News

    FDA clears Abbott’s Influenza A & B 2, Strep A 2 assays

    October 25, 2018

    The Influenza A & B 2 assay can detect and differentiate influenza A and B in 13 minutes, while the Strep A 2 assay detects group A streptococcus bacterial nucleic acid in 6 minutes.

  • 1
    News

    Length of stay, complications predict readmission for cirrhosis patients

    October 25, 2018

    PHILADELPHIA – Patients with cirrhosis have a higher risk of hospital readmission if their length of stay is less than 4 days, if they have cirrhosis-related complications, and if they are discharged to an extended-care facility or to home health care, according to a recent presentation at the annual meeting of the American College of Gastroenterology.

  • 1
    News

    FDA approves Xofluza for treatment of influenza

    October 24, 2018

    The FDA has approved Xofluza for acute uncomplicated influenza in people aged 12 years or older who have been symptomatic for 48 hours or less.

  • 1
    News

    Stroke risk in elderly following AMI extends to 12 weeks

    October 24, 2018

    ATLANTA – The prolonged period of heightened risk was evident in patients with both STEMI and NSTEMI.

  • 1
    News

    Drug overdose deaths down since late 2017

    October 23, 2018

    Longer-term trend, however, shows an increase of 2.7% during the 12 months ending in March 2018, compared with March 2017.

  • 1
    News

    Reducing alarm fatigue

    October 22, 2018

    A centralized monitoring system might help reduce unimportant alarms with no increase in cardiopulmonary arrest events.

  • 1
    News

    Readmission to non-index hospital following acute stroke linked to worse outcomes

    October 22, 2018

    ATLANTA – Study adds to the stroke literature on nationwide estimates of 30-day readmissions.

  • 1
    News

    Blood test may obviate need for head CTs in brain trauma evaluation

    October 20, 2018

    SAN DIEGO – A biomarker blood test to evaluate patients for suspected TBI was associated with a high negative predictive value in a large trial.

Previous1 … 227 228 229 230 231 … 401Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences